To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas
Clinical trial NCT03277209 · TERMINATED
Trial details
- NCT number
- NCT03277209
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2019-12-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.